Specifically, taking advantage from our previous work, we have designed an isoflavone with the aim to target simultaneously the Hh pathway at both upstream and downstream level, i.e., Smo and Gli1 respectively, and identify an innovative approach to limit tumor growth. This evidence concerns the gene GLI1 and neoplasm.